M W Decker - JoVE Visualize

Showing results (61-70 of 69) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 69 results.

Journal of Physiology, Paris|October 28, 1998

The role of neuronal nicotinic acetylcholine receptors in antinociception: effects of ABT-594M W Decker, P Curzon, M W Holladay, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterizationA W Bannon, M W Decker, P Curzon, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997

ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeysM W Decker, A W Bannon, P Curzon, et al.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 15, 2006

TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonistsM Cui, P Honore, C Zhong, et al.

Journal of Medicinal Chemistry|January 31, 1997

Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing propertiesN H Lin, D E Gunn, K B Ryther, et al.

Journal of Medicinal Chemistry|March 4, 1998

Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptorsM W Holladay, J T Wasicak, N H Lin, et al.

Pharmacology, Biochemistry, and Behavior|May 1, 1997

Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivoC A Briggs, D J Anderson, J D Brioni, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in miceM W Holladay, H Bai, Y Li, et al.

British Journal of Pharmacology|October 4, 2006

Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonistO El-Kouhen, S G Lehto, J B Pan, et al.

Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 69 results.

Journal of Physiology, Paris|October 28, 1998

The role of neuronal nicotinic acetylcholine receptors in antinociception: effects of ABT-594M W Decker, P Curzon, M W Holladay, et al.

The Journal of Pharmacology and Experimental Therapeutics|May 15, 1998

ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterizationA W Bannon, M W Decker, P Curzon, et al.

The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997

ABT-089 [2-methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A novel cholinergic channel modulator with effects on cognitive performance in rats and monkeysM W Decker, A W Bannon, P Curzon, et al.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 15, 2006

TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonistsM Cui, P Honore, C Zhong, et al.

Journal of Medicinal Chemistry|January 31, 1997

Structure-activity studies on 2-methyl-3-(2(S)-pyrrolidinylmethoxy) pyridine (ABT-089): an orally bioavailable 3-pyridyl ether nicotinic acetylcholine receptor ligand with cognition-enhancing propertiesN H Lin, D E Gunn, K B Ryther, et al.

Journal of Medicinal Chemistry|March 4, 1998

Identification and initial structure-activity relationships of (R)-5-(2-azetidinylmethoxy)-2-chloropyridine (ABT-594), a potent, orally active, non-opiate analgesic agent acting via neuronal nicotinic acetylcholine receptorsM W Holladay, J T Wasicak, N H Lin, et al.

Pharmacology, Biochemistry, and Behavior|May 1, 1997

Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivoC A Briggs, D J Anderson, J D Brioni, et al.

Bioorganic & Medicinal Chemistry Letters|January 5, 1999

Structure-activity studies related to ABT-594, a potent nonopioid analgesic agent: effect of pyridine and azetidine ring substitutions on nicotinic acetylcholine receptor binding affinity and analgesic activity in miceM W Holladay, H Bai, Y Li, et al.

British Journal of Pharmacology|October 4, 2006

Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonistO El-Kouhen, S G Lehto, J B Pan, et al.

Pageof 7